Daijiro Kabata

A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19

Yohei Doi, Masaya Hibino, Ryota Hase et al. · Antimicrobial Agents and Chemotherapy · 2020 · 231 citations · Full text

Open-label Trial, Late Favipiravir Therapy, Clinical Infectious Disease +14

Drug retention and discontinuation reasons between seven biologics in patients with rheumatoid arthritis -The ANSWER cohort study-

Kosuke Ebina, Motomu Hashimoto, Wataru Yamamoto et al. · PLoS ONE · 2018 · 118 citations · Full text

Disease Activity Score, Pharmacotherapy, Inflammatory Arthritis +16

Serum albumin as a risk factor for death in patients with prolonged sepsis: An observational study

Ryosuke Takegawa, Daijiro Kabata, Kentaro Shimizu et al. · Journal of Critical Care · 2019 · 91 citations · Full text

ISSLS PRIZE IN CLINICAL SCIENCE 2019: clinical importance of trunk muscle mass for low back pain, spinal balance, and quality of life—a multicenter cross-sectional study

Yusuke Hori, Masatoshi Hoshino, Kazuhide Inage et al. · European Spine Journal · 2019 · 76 citations

Clinical Importance, Spinal Balance, Trunk Muscle Mass +10

Efficacy and safety of super selective bronchial artery coil embolisation for haemoptysis: a single-centre retrospective observational study

Hideo Ishikawa, Masahiko Hara, Misaki Ryuge et al. · BMJ Open · 2017 · 70 citations · Full text